{"id":"streptozotocin","rwe":[],"tags":[],"safety":{"commonSideEffects":[{"effect":"Nausea","drugRate":"≥20%","severity":"serious"},{"effect":"Vomiting","drugRate":"≥20%","severity":"serious"},{"effect":"Diarrhea","drugRate":"reported","severity":"unknown"},{"effect":"Hepatic toxicity","drugRate":"reported","severity":"unknown"},{"effect":"Hematological toxicity","drugRate":"reported","severity":"unknown"},{"effect":"Mild to moderate abnormalities of glucose tolerance","drugRate":"reported","severity":"unknown"},{"effect":"Insulin shock with hypoglycemia","drugRate":"reported","severity":"unknown"},{"effect":"Nephrogenic diabetes insipidus","drugRate":"reported","severity":"unknown"},{"effect":"Local inflammation (edema, erythema, burning, tenderness)","drugRate":"reported","severity":"unknown"}],"contraindications":["Anemia","Bacterial infectious disease","Blood coagulation disorder","Bone marrow depression","Breastfeeding (mother)","Dehydration","Diabetes mellitus","Disease of liver","Infectious disease","Kidney disease","Leukopenia","Mycosis","Pregnancy, function","Protozoal Infection","Thrombocytopenic disorder","Viral disease"]},"trials":[],"_chembl":{"chemblId":"CHEMBL1977579","moleculeType":"Small molecule","molecularWeight":"265.22"},"aliases":[],"patents":[],"pricing":[],"_fixedAt":"2026-03-30T12:05:19.938077","offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"modality":"Small Molecule"},"_scrapedAt":"2026-03-28T00:53:39.348Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Pancreatic Neuroendocrine Tumor","diseaseId":"pancreatic-neuroendocrine-tumor","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"_fixedFields":["sideEffects","modality→Small Molecule"],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03813407","phase":"PHASE3","title":"An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With Hyperkalaemia","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2019-04-02","conditions":"Hyperkalaemia","enrollment":140},{"nctId":"NCT03217097","phase":"NA","title":"MGMT-NET: O6-methylguanine-DNA Methyltransferase (MGMT) Status in Neuroendocrine Tumors: Predictive Factor of Response to Alkylating Agents","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2018-10-16","conditions":"Neuroendocrine Tumors","enrollment":116},{"nctId":"NCT07083232","phase":"PHASE4","title":"The Effect of Sitagliptin, Pioglitazone and Dapagliflozine on Myocardial Infarction in Diabetic Rats","status":"COMPLETED","sponsor":"Al-Azhar University","startDate":"2024-10-30","conditions":"Diabetic, Myocardial Infarction","enrollment":50},{"nctId":"NCT07036796","phase":"PHASE2","title":"Effect of Melatonin in Patients With Diabetic Peripheral Neuropathy","status":"RECRUITING","sponsor":"Ain Shams University","startDate":"2025-07-04","conditions":"Diabetic Peripheral Neuropathy, Diabetic Neuropathy, Diabetic Peripheral Neuropathy in Type 2 Diabetic Patients","enrollment":60},{"nctId":"NCT02246127","phase":"PHASE3","title":"Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor","status":"COMPLETED","sponsor":"Grupo Espanol de Tumores Neuroendocrinos","startDate":"2014-10-27","conditions":"Neuroendocrine Tumors","enrollment":141},{"nctId":"NCT03351296","phase":"PHASE2","title":"Two Chemotherapy Regimens Plus or Minus Bevacizumab","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2018-06-26","conditions":"Pancreatic Cancer","enrollment":140},{"nctId":"NCT04217590","phase":"PHASE3","title":"Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese Subjects","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2020-11-16","conditions":"Hyperkalemia","enrollment":134},{"nctId":"NCT02788201","phase":"PHASE2","title":"Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-03-27","conditions":"Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Neoplasms","enrollment":8},{"nctId":"NCT03758014","phase":"PHASE2, PHASE3","title":"Studies of Chlorogenic Acid for Injection for Safety and Efficacy of Grade IV GBM Patients","status":"UNKNOWN","sponsor":"Sichuan J.Z. Bio-chemical Science and Technology Development Co., Ltd","startDate":"2018-11-27","conditions":"GBM","enrollment":200},{"nctId":"NCT01362530","phase":"PHASE3","title":"A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2011-09-13","conditions":"Chemotherapy Induced Nausea and Vomiting","enrollment":307},{"nctId":"NCT00609765","phase":"PHASE2","title":"Avastin, Fluorouracil, Doxorubicin and Streptozocin in Locally Advanced and Metastatic Pancreatic Endocrine Tumors","status":"TERMINATED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2007-08","conditions":"Pancreatic Cancer","enrollment":1},{"nctId":"NCT00094497","phase":"PHASE3","title":"Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)","status":"COMPLETED","sponsor":"Collaborative Group for Adrenocortical Carcinoma Treatment","startDate":"2004-06","conditions":"Carcinoma, Adrenal Cortical","enrollment":304},{"nctId":"NCT00004688","phase":"PHASE2","title":"Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms","status":"COMPLETED","sponsor":"Emory University","startDate":"1996-08","conditions":"Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Mixed Gliomas","enrollment":35},{"nctId":"NCT00448136","phase":"PHASE2","title":"A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2007-07","conditions":"Neoplasms","enrollment":83},{"nctId":"NCT00602082","phase":"PHASE2","title":"Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors","status":"COMPLETED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2005-08","conditions":"Gastrointestinal Carcinoid Tumor, Islet Cell Tumor","enrollment":84},{"nctId":"NCT00003543","phase":"PHASE1","title":"Monoclonal Antibody Therapy Plus Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"1998-06","conditions":"Colorectal Cancer","enrollment":18},{"nctId":"NCT00001165","phase":"PHASE2","title":"Combination Chemotherapy in Patients With Zollinger-Ellison Syndrome and Tumors of the Pancreas","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1978-09","conditions":"Islet Cell Adenoma, Neoplasm Metastasis, Zollinger Ellison Syndrome","enrollment":999}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":38193,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"phase_3","status":"active","brandName":"Streptozotocin","genericName":"Streptozotocin","companyName":"Hoffmann-La Roche","companyId":"roche","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Streptozotocin is a small molecule DNA inhibitor used as an alkylating antineoplastic agent. It is particularly toxic to the insulin-producing beta cells of the pancreas and is used in medicine to treat certain cancers, including those of the islets of Langerhans, and conditions such as Zollinger-Ellison Syndrome.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}